Literature DB >> 28414116

The Largest European Single-Center Experience: 300 Laparoscopic Pancreatic Resections.

Safi Dokmak1, Fadhel Samir Ftériche2, Béatrice Aussilhou2, Philippe Lévy3, Philippe Ruszniewski3, Jérome Cros4, Marie Pierre Vullierme5, Linda Khoy Ear6, Jacques Belghiti2, Alain Sauvanet2.   

Abstract

BACKGROUND: Although laparoscopic pancreatic resection (LPR) has become routine, large single-center series are still lacking. Our aim was to analyze the results of a large European single-center series of LPR. STUDY
DESIGN: Between January 2008 and September 2015, 300 LPRs were performed and studied prospectively, including 165 (55%) distal pancreatectomies, 68 (23%) pancreaticoduodenectomies (PDs), 30 (10%) enucleations, 35 (11%) central pancreatectomies, and 2 (1%) total pancreatectomies.
RESULTS: Mean age was 54 ± 15.4 years old (range 17 to 87 years), and most patients were women (58%). Laparoscopic pancreatic resection was performed for malignancy (46%), low potential malignant (44%), or benign (10%) diseases. The mean operative durations were 211 ± 102 minutes (range 30 to 540 minutes) for the entire population and 351 ± 59 minutes (range 240 to 540 minutes) for PD, and decreased with the learning curve. Mean blood loss was 229 ± 269 mL (range 0 to 1,500 mL), and 13 patients (4%) received transfusions. Conversion to an open procedure was required in 12 patients (4%), and only 5 in the last 250 patients (14% vs 2%; p < 0.001). Mortality occurred in 4 (1.3%) patients and only after PD (5.8%). Common complications were pancreatic fistula (n = 124, 41%), bleeding (n = 35, 12%), and reoperation (n = 28, 9%). The postoperative outcomes were less favorable in procedures with a reconstruction phase (n = 105) than in those without (n = 195), with increased mortality (3.8% vs 0%; p = 0.04), overall morbidity (76% vs % 52%; p < 0.001), and mean hospital stay (26 ± 15 days vs 16 ± 10 days; p < 0.001).
CONCLUSIONS: Laparoscopic pancreatic resection without a reconstruction phase has excellent outcomes; LPR with a reconstruction phase, especially PD, has less favorable outcomes, and further randomized studies are required to draw conclusions on the safety and benefits of this approach.
Copyright © 2017 American College of Surgeons. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2017        PMID: 28414116     DOI: 10.1016/j.jamcollsurg.2017.04.004

Source DB:  PubMed          Journal:  J Am Coll Surg        ISSN: 1072-7515            Impact factor:   6.113


  13 in total

1.  The superior approach with the stomach roll-up technique improves intraoperative outcomes and facilitates learning laparoscopic distal pancreatectomy: a comparative study between the superior and inferior approach.

Authors:  Takanori Morikawa; Masaharu Ishida; Tatsuyuki Takadate; Tatsuo Hata; Masahiro Iseki; Kei Kawaguchi; Hideo Ohtsuka; Masamichi Mizuma; Hiroki Hayashi; Kei Nakagawa; Fuyuhiko Motoi; Takashi Kamei; Takeshi Naitoh; Michiaki Unno
Journal:  Surg Today       Date:  2019-07-27       Impact factor: 2.549

2.  Surgical outcomes of laparoscopic distal pancreatectomy in elderly and octogenarian patients: a single-center, comparative study.

Authors:  Ke Chen; Yu Pan; Yi-Ping Mou; Jia-Fei Yan; Ren-Chao Zhang; Miao-Zun Zhang; Jia-Yu Zhou; Xian-Fa Wang; Hendi Maher; Qi-Long Chen
Journal:  Surg Endosc       Date:  2018-10-25       Impact factor: 4.584

3.  Association of Mentorship and a Formal Robotic Proficiency Skills Curriculum With Subsequent Generations' Learning Curve and Safety for Robotic Pancreaticoduodenectomy.

Authors:  MaryJoe K Rice; Jacob C Hodges; Johanna Bellon; Jeffrey Borrebach; Amr I Al Abbas; Ahmad Hamad; L Mark Knab; A James Moser; Amer H Zureikat; Herbert J Zeh; Melissa E Hogg
Journal:  JAMA Surg       Date:  2020-07-01       Impact factor: 14.766

4.  Visceral Obesity and Open Passive Drainage Increase the Risk of Pancreatic Fistula Following Distal Pancreatectomy.

Authors:  Charles Vanbrugghe; Maxime Ronot; François Cauchy; Christian Hobeika; Safi Dokmak; Béatrice Aussilhou; Emilia Ragot; Sébastien Gaujoux; Olivier Soubrane; Philippe Lévy; Alain Sauvanet
Journal:  J Gastrointest Surg       Date:  2018-08-17       Impact factor: 3.452

5.  Laparoscopic pancreaticoduodenectomy with reconstruction of the mesentericoportal vein with the parietal peritoneum and the falciform ligament.

Authors:  Safi Dokmak; Béatrice Aussilhou; Mélanie Calmels; Houcine Maghrebi; Fadhel Samir Ftériche; Olivier Soubrane; Alain Sauvanet
Journal:  Surg Endosc       Date:  2018-01-18       Impact factor: 4.584

6.  Changing trends and outcomes associated with the adoption of minimally-invasive pancreato-biliary surgery: Contemporary experience of a 'self-taught' early adopter in Southeast Asia.

Authors:  Brian K P Goh; Gerald Zeng; Tze-Yi Low; Darren W Chua; Ye-Xin Koh; Kai-Inn Lim
Journal:  J Minim Access Surg       Date:  2020 Oct-Dec       Impact factor: 1.407

7.  Changing trends and outcomes associated with the adoption of minimally invasive pancreatic surgeries: A single institution experience with 150 consecutive procedures in Southeast Asia.

Authors:  Brian K Goh; Tze Yi Low; Ye Xin Koh; Ser Yee Lee; Jin-Yao Teo; Juinn Huar Kam; Prema Raj Jeyaraj; Peng-Chung Cheow; Pierce K Chow; London L Ooi; Alexander Y Chung; Chung Yip Chan
Journal:  J Minim Access Surg       Date:  2020 Oct-Dec       Impact factor: 1.407

Review 8.  Updated Principles of Surgical Management of Pancreatic Neuroendocrine Tumours (pNETs): What Every Surgeon Needs to Know.

Authors:  Charles de Ponthaud; Fabrice Menegaux; Sébastien Gaujoux
Journal:  Cancers (Basel)       Date:  2021-11-27       Impact factor: 6.639

9.  Comparison of Perioperative and Oncological Outcomes of Hybrid and Totally Laparoscopic Pancreatoduodenectomy.

Authors:  Chengfang Wang; Ruizhao Qi; Huixing Li; Xianjie Shi
Journal:  Med Sci Monit       Date:  2020-04-26

10.  Perioperative and Long-term Oncological Results of Minimally Invasive Pancreatoduodenectomy as Hybrid Technique - A Matched Pair Analysis of 120 Cases.

Authors:  Steffen Deichmann; Louisa Romina Bolm; Kim Christin Honselmann; Ulrich Friedrich Wellner; Hryhoriy Lapshyn; Tobias Keck; Dirk Bausch
Journal:  Zentralbl Chir       Date:  2018-05-02       Impact factor: 0.942

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.